新聞Parpharm has issues with recall of one lot of treprostinil.Par Pharmaceutical, a subsidiary of Endo International, announced a voluntary recall of one lot of treprostinil injection 20mg/20mL due to the potential for the presence of silicone particulates in the product solution.
新聞Parpharm launches ibuprofen-famotidine 800 mg/26.6 mg tablets.DUBLIN, March 26, 2024 /PRNewswire/ - Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS(R).
新聞Parpharm launched generic version of the medication DUEXIS on Feb 26th '24.DUBLIN - Endo International plc (OTC: OTC:ENDPQ) through its subsidiary Par Pharmaceutical, Inc., has recently launched a generic version of the medication DUEXIS(R), which combines ibuprofen and famotidine.
